Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Published loading...Updated

Benitec Biopharma (NASDAQ:BNTC) Director Purchases $220,551.60 in Stock

Suvretta Capital Management acquired over 180,000 shares in late December, signaling increased institutional confidence with director ownership up 0.52%.

Summary by marketbeat.com
Benitec Biopharma Limited (NASDAQ:BNTC - Get Free Report) Director Suvretta Capital Management, L purchased 16,836 shares of the business's stock in a transaction on Friday, December 26th. The shares were bought at an average cost of $13.10 per share, for a total transaction of $220,551.60. Following the completion of the transaction, the director directly owned 9,634,395 shares in the company, valued at $126,210,574.50. This trade represents a …

3 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Tuesday, December 30, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal